Namzaric Titration Pack
RxNorm 1858971
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1858971 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Namzaric Titration Pack.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PSNPrescribable
Prescribable Name (PSN):
Namzaric Titration Pack
(Atom ID: 8698897)
SYPrescribable
Synonym (SY):
Namzaric Titration Pack
(Atom ID: 8698896)
BPCKPrescribable
Brand Name Pack (BPCK):
{7 (24 HR donepezil hydrochloride 10 mg / memantine hydrochloride 14 mg Extended Release Oral Capsule [Namzaric]) / 7 (24 HR donepezil hydrochloride 10 mg / memantine hydrochloride 21 mg Extended Release Oral Capsule [Namzaric]) / 7 (24 HR donepezil hydrochloride 10 mg / memantine hydrochloride 28 mg Extended Release Oral Capsule [Namzaric]) / 7 (24 HR donepezil hydrochloride 10 mg / memantine hydrochloride 7 mg Extended Release Oral Capsule [Namzaric]) } Pack [Namzaric Titration Pack]
(Atom ID: 12373442)
Patient Education
Donepezil
Donepezil is used to treat dementia (a brain disorder that affects the ability to remember, think clearly, communicate, and perform daily activities and may cause changes in mood and personality) in people who have Alzheimer's disease (AD; a brain disease that slowly destroys the memory and the ability to think, learn, communicate and handle daily activities). Donepezil is in a class of medications called cholinesterase inhibitors. It improves mental function (such as memory, attention, the ability to interact with others, speak, think clearly, and perform regular daily activities) by increasing the amount of a certain naturally occurring substance in the brain. Donepezil may improve the ability to think and remember or slow the loss of these abilities in people who have AD. However, donepezil will not cure AD or prevent the loss of mental abilities at some time in the future.
[Learn More]
Memantine
Memantine is used to treat the symptoms of Alzheimer's disease (AD; a brain disease that slowly destroys the memory and the ability to think, learn, communicate and handle daily activities). Memantine is in a class of medications called NMDA receptor antagonists. It works by decreasing abnormal activity in the brain. Memantine may improve the ability to think and remember or may slow the loss of these abilities in people who have AD. However, memantine will not cure AD or prevent the loss of these abilities at some time in the future.
[Learn More]
* Please review the disclaimer below.
